Atlas Trials

To Evaluate the Safety, Tolerability, and Preliminary Antitumor Activity of STR-P004

Clinical trial NCT07245251 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07245251
Sponsor
Starna Therapeutics
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Lymphobkastic Leukemia
Start date
2025-12-03
Primary completion
2026-11-02
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.